Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content.
Diabetes. 2010 Jul;59(7):1640-7. doi: 10.2337/db09-1200. Epub 2010 Mar 31.
Diabetes. 2010.
PMID: 20357364
Free PMC article.
Determinants of exercise-induced fat oxidation in obese women and men.
Haufe S, Engeli S, Budziarek P, Utz W, Schulz-Menger J, Hermsdorf M, Wiesner S, Otto C, Fuhrmann JC, Luft FC, Boschmann M, Jordan J.
Haufe S, et al. Among authors: budziarek p.
Horm Metab Res. 2010 Mar;42(3):215-21. doi: 10.1055/s-0029-1242745. Epub 2009 Nov 23.
Horm Metab Res. 2010.
PMID: 19937568
Clinical Trial.
Item in Clipboard
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, Berlan M, Marques MA, Sweep FC, Luft FC, Lafontan M, Jordan J.
Birkenfeld AL, et al. Among authors: budziarek p.
Diabetes. 2008 Dec;57(12):3199-204. doi: 10.2337/db08-0649. Epub 2008 Oct 3.
Diabetes. 2008.
PMID: 18835931
Free PMC article.
Item in Clipboard
Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients.
Boschmann M, Engeli S, Dobberstein K, Budziarek P, Strauss A, Boehnke J, Sweep FC, Luft FC, He Y, Foley JE, Jordan J.
Boschmann M, et al. Among authors: budziarek p.
J Clin Endocrinol Metab. 2009 Mar;94(3):846-52. doi: 10.1210/jc.2008-1400. Epub 2008 Dec 16.
J Clin Endocrinol Metab. 2009.
PMID: 19088168
Clinical Trial.
Item in Clipboard
Aliskiren combined with losartan in type 2 diabetes and nephropathy.
Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators.
Parving HH, et al.
N Engl J Med. 2008 Jun 5;358(23):2433-46. doi: 10.1056/NEJMoa0708379.
N Engl J Med. 2008.
PMID: 18525041
Free article.
Clinical Trial.
Item in Clipboard
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
DREAM Trial Investigators; Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.
DREAM Trial Investigators, et al.
Diabetes Care. 2008 May;31(5):1007-14. doi: 10.2337/dc07-1868. Epub 2008 Feb 11.
Diabetes Care. 2008.
PMID: 18268075
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite